{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:20:10Z","timestamp":1792819210078,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      The diagnosis and localization of insulinomas remain challenging. Imaging with contrast-enhanced CT, PET with somatostatin analogs, MRI, and endoscopic ultrasonography is often inconclusive. GLP1 receptor radioligands can specifically target insulinomas. A recent multicenter trial reported the superior performance of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-NODAGA-Exendin-4 (EX) PET\/CT for the detection of benign insulinomas.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>Fifty EX-PET\/CTs (individually authorized by the French Medicine Agency) were performed on 44 patients with a suspected sporadic insulinoma, based on biochemistry and clinical signs, but without a target lesion identified by imaging. A composite reference standard was based on postsurgical histology and\/or follow-up data over 6\u201345 months after the EX-PET\/CT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The examination-based EX-PET\/CT positivity rate was 62% (31\/50), equivocal 0. Positive EX-PET\/CTs were confirmed by the outcomes of all 29 EX-guided resections (PPV 100%), including 2 re-operations following partial resection. Furthermore, the suspected diagnosis of an insulinoma was abandoned in 12 patients after 14 of 19 negative EX-PET\/CTs. Suspicion of occult insulinoma remained in 5 patients. EX-PET\/CT performed similarly well in patients treated by antihypoglycemic drugs and\/or younger than 18 years. Since no extra-pancreatic EX abnormal foci were observed, the EX-PET\/CT field-of-view to the upper abdomen should be sufficient. Only 1 patient experienced symptomatic hypoglycemia after EX injection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In cases of suspected insulinomas with nondiagnostic imaging, the performance of EX-PET\/CT for the detection of nonmalignant sporadic insulinomas was excellent, with a 29\/50 (58%) rate of major impact on patients\u2019 management. A negative EX-PET\/CT appears to be a confident predictor to rule out the presence of sporadic insulinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005946","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:00:07Z","timestamp":1762974007000},"page":"1109-1119","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["68Ga-NODAGA-EXENDIN-4 PET\/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas"],"prefix":"10.1097","volume":"50","author":[{"given":"Cyrielle","family":"Aveline","sequence":"first","affiliation":[{"name":"Nuclear Medicine, Tenon Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0307-880X","authenticated-orcid":false,"given":"Timofei","family":"Rusu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Tenon Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Montravers","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Tenon Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Gaujoux","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP Piti\u00e9-Salp\u00eatri\u00e8re Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-0423","authenticated-orcid":false,"given":"Olivier","family":"Dubreuil","sequence":"additional","affiliation":[{"name":"Department of Digestive Oncology, Groupe Hospitalier Diaconesses Croix Saint Simon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Belle","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cochin Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gotthardt","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Noel","family":"Talbot","sequence":"additional","affiliation":[{"name":"Institut National des Sciences et Techniques Nucl\u00e9aires (INSTN), Saclay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"R1-20251114","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-013-9262-y","article-title":"Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature","volume":"24","author":"La Rosa","year":"2013","journal-title":"Endocr Pathol"},{"key":"R2-20251114","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/jc.2008-2031","article-title":"Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007","volume":"94","author":"Placzkowski","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20251114","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/ERC-19-0476","article-title":"Innovative imaging of insulinoma: the end of sampling? A review","volume":"27","author":"Christ","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"R4-20251114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R5-20251114","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20251114","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","article-title":"Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites","volume":"34","author":"Sadowski","year":"2016","journal-title":"J Clin Oncol"},{"key":"R7-20251114","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2967\/jnumed.121.262401","article-title":"Value of 68Ga-DOTATOC and carbidopa-assisted 18F-DOPA PET\/CT for insulinoma localization","volume":"63","author":"Imperiale","year":"2022","journal-title":"J Nucl Med"},{"key":"R8-20251114","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00259-002-0761-1","article-title":"Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results","volume":"29","author":"Gotthardt","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"R9-20251114","first-page":"2025","article-title":"[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting","volume":"47","author":"Wild","year":"2006","journal-title":"J Nucl Med"},{"key":"R10-20251114","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00259-012-2299-1","article-title":"Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc\/EDDA)NH2]-exendin-4 for the detection of insulinoma","volume":"40","author":"Sowa-Staszczak","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20251114","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00259-009-1363-y","article-title":"68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET","volume":"37","author":"Brom","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-20251114","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1007\/s00259-018-4101-5","article-title":"Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET\/CT, SPECT\/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study","volume":"45","author":"Antwi","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-20251114","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2967\/jnumed.111.087999","article-title":"PET of somatostatin receptor\u2013positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference","volume":"52","author":"Fani","year":"2011","journal-title":"J Nucl Med"},{"key":"R14-20251114","first-page":"1959","article-title":"Improved localization of insulinomas using 68Ga-NODAGA-exendin-4 PET\/CT","volume":"65","author":"Boss","year":"2024","journal-title":"J Nucl Med"},{"key":"R15-20251114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2967\/jnumed.115.167445","article-title":"Glucagon-like peptide-1 receptor PET\/CT with68 Ga-NOTA-Exendin-4 for detecting localized insulinoma: a prospective cohort study","volume":"57","author":"Luo","year":"2016","journal-title":"J Nucl Med"},{"key":"R16-20251114","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2967\/jnumed.115.157768","article-title":"Localization of hidden insulinomas with 68Ga-DOTA-Exendin-4 PET\/CT: a pilot study","volume":"56","author":"Antwi","year":"2015","journal-title":"J Nucl Med"},{"key":"R17-20251114","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/imj.15141","article-title":"Utility of Ga-DOTA-Exendin-4 positron emission tomography\u2013computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed ensdogenous hyperinsulinaemic hypoglycaemia","volume":"51","author":"Kalff","year":"2021","journal-title":"Intern Med J"},{"key":"R18-20251114","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s12020-015-0633-7","article-title":"Preoperative localization of adult nesidioblastosis using 68Ga-DOTA-exendin-4-PET\/CT","volume":"50","author":"Christ","year":"2015","journal-title":"Endocrine"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:01:06Z","timestamp":1763125266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005946","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"2025-01-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}